Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture

Toxicology in Vitro

Volumn 22, Issue 1, 2008, Pages 68-74

  Radad, Khaled ^a   Gille, Gabriele ^b   Rausch, Wolf Dieter ^c  

^a Assiut University   (Egypt)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Dopaminergic; Neurodegeneration; Parkinson's; Pesticides; Rotenone

Indexed keywords

ANTIBODY; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; ROTENONE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN LEVEL; CELL COUNT; CELL DENSITY; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; EMBRYO; GLIA CELL; IMMUNOREACTIVITY; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NONHUMAN; PARKINSON DISEASE; SUBSTANTIA NIGRA; TIME; ZONA COMPACTA;

ANIMALS; ASTROCYTES; CELL COUNT; CELLS, CULTURED; DOPAMINE; ENVIRONMENTAL POLLUTANTS; INSECTICIDES; MESENCEPHALON; MICE; NEURONS; PARKINSON DISEASE; ROTENONE; TIME FACTORS;

EID: 37249051817     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.08.015     Document Type: Article

References (31)

1. Ahmadi F.A., Linseman D.A., Grammatopoulos T.N., Jones S.M., Bouchard R.J., Freed C.R., Heidenreich K.A., and Zawada W.M. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons. J. Neurochem. 87 (2003) 914-921
2. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., and Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69 (1997) 1196-1203
3. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
4. Bove J., Prou D., Perier C., and Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2 (2005) 484-494
5. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
6. de Lau L.M., and Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 5 (2006) 525-535
7. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52 (1989) 381-389
8. Di Monte D.A. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?. Lancet Neurol. 2 (2003) 531-538
9. Dukes A.A., Korwek K.M., and Hastings T.G. The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells. Antioxid. Redox. Signal. 7 (2005) 630-638
10. Gao H.M., Hong J.S., Zhang W., and Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 22 (2002) 782-790
11. Giasson B.I., and Lee V.M. A new link between pesticides and Parkinson's disease. Nat. Neurosci. 3 (2000) 1227-1228
12. Greenamyre J.T., Betarbet R., Sherer T., and Panov A. Response: Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 24 (2001) 247
13. Jenner P. Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 24 (2001) 245-247
14. Kitazawa M., Anantharam V., and Kanthasamy A.G. Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic. Biol. Med. 31 (2001) 1473-1485
15. Kweon G.R., Marks J.D., Krencik R., Leung E.H., Schumacker P.T., Hyland K., and Kang U.J. Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J. Biol. Chem. 279 (2004) 51783-51792
16. Le Couteur D.G., Muller M., Yang M.C., Mellick G.D., and McLean A.J. Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev. Environ. Health 17 (2002) 51-64
17. Li A.A., Mink P.J., McIntosh L.J., Teta M.J., and Finley B. Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease. J. Occup. Environ. Med. 47 (2005) 1059-1087
18. Mogi M., Togari A., Kondo T., Mizuno Y., Komure O., Kuno S., Ichinose H., and Nagatsu T. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J. Neural Transm. 107 (2000) 335-341
19. Moon Y., Lee K.H., Park J.H., Geum D., and Kim K. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10. J. Neurochem. 93 (2005) 1199-1208
20. Nakamura K., Bindokas V.P., Marks J.D., Wright D.A., Frim D.M., Miller R.J., and Kang U.J. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited. Mol. Pharmacol. 58 (2000) 271-278
21. Pearce R.K., Owen A., Daniel S., Jenner P., and Marsden C.D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 104 (1997) 661-677
22. Radad K., Rausch W.D., and Gille G. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem. Int. 49 (2006) 379-386
23. Ren Y., Liu W., Jiang H., Jiang Q., and Feng J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J. Biol. Chem. 280 (2005) 34105-34112
24. Seaton T.A., Cooper J.M., and Schapira A.H. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res. 777 (1997) 110-118
25. Sherer T.B., Betarbet R., Kim J.H., and Greenamyre J.T. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci. Lett. 341 (2003) 87-90
26. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., and Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23 (2003) 10756-10764
27. Shimizu K., Matsubara K., Ohtaki K., and Shiono H. Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neurosci. Res. 46 (2003) 523-532
28. Testa C.M., Sherer T.B., and Greenamyre J.T. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res. Mol. Brain Res. 134 (2005) 109-118
29. Thiffault C., Langston J.W., and Di Monte D.A. Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res. 885 (2000) 283-288
30. Wang X., Qin Z.H., Leng Y., Wang Y., Jin X., Chase T.N., and Bennett M.C. Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells. J. Neurochem. 83 (2002) 1094-1102
31. Zhu C., Vourc'h P., Fernagut P.O., Fleming S.M., Lacan S., DiCarlo C.D., Seaman R.L., and Chesselet M.F. Variable effects of chronic subcutaneous administration of rotenone on striatal histology. J. Comp. Neurol. 478 (2004) 418-426